Obi Greenman
Director Ejecutivo en CERUS CORPORATION .
Fortuna: 5 M $ al 31/05/2024
Cargos activos de Obi Greenman
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CERUS CORPORATION | Director/Miembro de la Junta | 21/04/2011 | - |
| Director Ejecutivo | 21/04/2011 | - | |
| Presidente | 21/04/2011 | - | |
| Corporate Officer/Principal | 01/01/1999 | 01/08/2008 | |
| Ventas & Marketing | 01/08/2008 | 21/04/2011 |
Historial de carrera de Obi Greenman
Antiguos cargos conocidos de Obi Greenman.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/06/2010 | 11/08/2023 |
| Independent Dir/Board Member | 01/06/2010 | 11/08/2023 | |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/01/1995 | 01/01/1995 |
| CHINOOK THERAPEUTICS, INC. | Director/Miembro de la Junta | 23/06/2011 | - |
| Independent Dir/Board Member | 01/06/2010 | - |
Formación de Obi Greenman.
| Stanford University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Independent Dir/Board Member | 2 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| CERUS CORPORATION | Health Technology |
| BAXTER INTERNATIONAL INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Aduro BioTech, Inc.
 Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA. | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
- Bolsa de valores
- Insiders
- Obi Greenman
- Experiencia
